Skip to content

Now I have a better understanding of the model and the proteins involved. Let me provide a comprehensive review.

GO-CAM Model Review: BMP8B role in adipocyte differentiation inhibition (Human)

Model ID: gomodel:66e382fb00002243

Overview

This GO-CAM model represents the molecular mechanisms by which BMP8B (Bone Morphogenetic Protein 8B) inhibits adipocyte differentiation in humans. The model captures a signaling cascade from the extracellular BMP8B protein through the ACVR1B receptor to SMAD2 and SMAD3 transcription factors, which ultimately leads to the negative regulation of cell differentiation.

Model Components

  1. BMP8B (UniProtKB:P34820)
  2. Annotated with cytokine activity (GO:0005125)
  3. Located in extracellular space (GO:0005615)
  4. Part of negative regulation of cell differentiation (GO:0045596)

  5. Provides input for ACVR1B's activin receptor activity

  6. ACVR1B (UniProtKB:P36896)

  7. Annotated with activin receptor activity, type I (GO:0016361)
  8. Located in plasma membrane (GO:0005886)
  9. Part of negative regulation of cell differentiation (GO:0045596)

  10. Directly positively regulates both SMAD2 and SMAD3 transcription factors

  11. SMAD2 (UniProtKB:Q15796)

  12. Annotated with DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)
  13. Located in nucleus (GO:0005634)

  14. Part of negative regulation of cell differentiation (GO:0045596)

  15. SMAD3 (UniProtKB:P84022)

  16. Annotated with DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)
  17. Located in nucleus (GO:0005634)
  18. Part of negative regulation of cell differentiation (GO:0045596)

Causal Flow

The model represents a clear causal flow from extracellular signaling to transcriptional regulation: 1. BMP8B in the extracellular space provides input for ACVR1B receptor at the plasma membrane 2. ACVR1B directly positively regulates SMAD2 and SMAD3 3. SMAD2 and SMAD3 function as transcriptional activators in the nucleus 4. All components are part of the negative regulation of cell differentiation

Literature Support

The model is supported by several publications cited in the annotations: - PMID:24378993 supports the role of SMAD3 as a DNA-binding transcription activator - PMID:9892009 supports ACVR1B's direct positive regulation of SMAD2 and SMAD3 - PMID:9032295 supports ACVR1B localization in the plasma membrane - PMID:21145499 supports SMAD2 nuclear localization

QC Assessment

Strengths:

  1. Biological Accuracy: The model correctly represents the established pathway by which BMP signaling through ACVR1B leads to SMAD2/3 activation and nuclear localization to regulate transcription.

  2. Correct GO Terms: The molecular functions (cytokine activity, receptor activity, transcription activator activity) are appropriately chosen for each protein.

  3. Appropriate Causal Relations: The causal relations (RO:0002409 for "provides input for" and RO:0002629 for "directly positively regulates") accurately depict the flow of information through this signaling pathway.

  4. Subcellular Localization: The model correctly annotates proteins with their proper cellular compartments (extracellular for BMP8B, plasma membrane for ACVR1B, and nucleus for SMAD2/3).

  5. Evidence Support: Each assertion is backed by appropriate literature evidence with relevant PMIDs.

Areas for Improvement:

  1. Adipocyte Context: While the title specifies "BMP8B role in adipocyte differentiation inhibition," there is no explicit annotation to XAO:0006041 (adipocyte) in the activity components, despite it being listed in the objects. This cellular context should be included to better align with the model's title.

  2. Mechanistic Detail: The model doesn't capture the phosphorylation of SMAD2/3 by ACVR1B, which is a critical mechanistic detail of this pathway. Based on PMID:9892009, ACVR1B phosphorylates SMAD2/3 to enable their nuclear translocation.

  3. SMAD Complex Formation: While individual SMAD proteins are represented, the formation of SMAD2/3-SMAD4 complexes, which is essential for their transcriptional activity, is not included. According to the literature (PMID:21145499), activated SMADs form complexes that regulate transcription.

  4. Downstream Target Genes: The model doesn't include specific target genes whose expression is regulated by SMAD2/3 to inhibit adipocyte differentiation.

  5. Completeness of Pathway: BMP8B is shown interacting directly with ACVR1B, but BMPs typically require both Type I and Type II receptors for signaling. The model doesn't include a Type II receptor component.

Recommendations:

  1. Add Adipocyte Context: Include the adipocyte term (XAO:0006041) as the "occurs_in" location for relevant activities to make the cellular context explicit.

  2. Include SMAD4: Add SMAD4 and represent the formation of SMAD complexes, which are crucial for transcriptional regulation.

  3. Add Phosphorylation Mechanism: Include annotations that capture the phosphorylation of SMAD2/3 by ACVR1B.

  4. Include Type II Receptor: BMP signaling typically requires both Type I and Type II receptors. Consider adding a Type II BMP receptor to complete the receptor complex.

  5. Add Target Genes: If known, include specific target genes regulated by SMAD2/3 that affect adipocyte differentiation.

Conclusion:

This GO-CAM model accurately represents the core signaling cascade through which BMP8B inhibits adipocyte differentiation via ACVR1B and SMAD2/3 activation. While the fundamental pathway is correct, additional molecular details would strengthen the model's biological completeness. The model aligns with current literature on BMP signaling through SMAD transcription factors and provides a valuable resource for understanding BMP8B's role in the negative regulation of cell differentiation.